Caisse Des Depots Et Consignations Gilead Sciences, Inc. Transaction History
Caisse Des Depots Et Consignations
- $2.35 Trillion
- Q3 2025
A detailed history of Caisse Des Depots Et Consignations transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caisse Des Depots Et Consignations holds 61,056 shares of GILD stock, worth $7.58 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
61,056
Previous 73,552
16.99%
Holding current value
$7.58 Million
Previous $8.15 Billion
16.89%
% of portfolio
0.29%
Previous 0.34%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...